Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person p16INK4A W110* [cytosol]

Class:IdEntityWithAccessionedSequence:9632585
_displayNamep16INK4A W110* [cytosol]
_timestamp2019-06-13 15:35:12
compartment[Compartment:70101] cytosol
created[InstanceEdit:9632589] Orlic-Milacic, Marija, 2018-12-19
crossReference[DatabaseIdentifier:9632641] COSMIC:COSM13783
[DatabaseIdentifier:9632648] COSMIC:COSV58682976
[DatabaseIdentifier:9632650] COSMIC:COSV58682827
disease[Disease:1500689] cancer
[Disease:1614289] melanoma
[Disease:2328001] skin squamous cell carcinoma
[Disease:1655484] kidney cancer
[Disease:1248679] head and neck squamous cell carcinoma
[Disease:2328083] larynx cancer
[Disease:6802256] thyroid carcinoma
[Disease:9632204] Barrett's esophagus
[Disease:1996318] astrocytoma
[Disease:2327989] bile duct carcinoma
[Disease:9632339] esophagus adenocarcinoma
[Disease:9630862] esophagus squamous cell carcinoma
[Disease:1500699] lung cancer
[Disease:1981182] lung squamous cell carcinoma
[Disease:9630864] pancreatic ductal adenocarcinoma
[Disease:9632619] sebaceous carcinoma
[Disease:1500687] stomach cancer
[Disease:1655468] thymus cancer
[Disease:1493885] bladder carcinoma
[Disease:9630843] oral squamous cell carcinoma
[Disease:2317476] acute lymphocytic leukemia
[Disease:2317358] endometrial cancer
[Disease:1247848] non-small cell lung carcinoma
[Disease:9632612] fibrous histiocytoma
[Disease:9630850] pharynx squamous cell carcinoma
[Disease:9632101] vulva squamous cell carcinoma
[Disease:9632647] trachea squamous cell carcinoma
endCoordinate109
hasModifiedResidue[NonsenseMutation:9649383] Nonsense mutation at L-tryptophan 110
literatureReference[LiteratureReference:9632578] CDKN2A/p16 is inactivated in most melanoma cell lines
modified[InstanceEdit:9632643] Orlic-Milacic, Marija, 2018-12-20
[InstanceEdit:9632651] Orlic-Milacic, Marija, 2018-12-20
[InstanceEdit:9645193] Orlic-Milacic, Marija, 2019-05-06
[InstanceEdit:9648380] Orlic-Milacic, Marija, 2019-06-06
[InstanceEdit:9649386] Orlic-Milacic, Marija, 2019-06-13
namep16INK4A W110*
p16INK4A W110TER
p16INK4A Trp110TER
p16INK4A Trp110*
CDKN2A W110TER
CDKN2A Trp110TER
CDKN2A W110*
CDKN2A Trp110*
referenceEntity[ReferenceGeneProduct:87039] UniProt:P42771 CDKN2A [Homo sapiens]
species[Species:48887] Homo sapiens
stableIdentifier[StableIdentifier:9632592] R-HSA-9632585.2
startCoordinate1
(hasMember)[CandidateSet:9630804] p16INK4A LoF mutants (CDK4/6) [cytosol] [Homo sapiens]
(updatedInstance)[_UpdateTracker:9900644] Update Tracker - [EntityWithAccessionedSequence:9632585] p16INK4A W110* [cytosol] - v70:[addHasModifiedResidue]
[Change default viewing format]
No pathways have been reviewed or authored by p16INK4A W110* [cytosol] (9632585)